Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Michael O'Riordan

June 25, 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Daily News

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Todd Neale

August 15, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Daily News

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Michael O'Riordan

February 07, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Todd Neale

August 12, 2022

News Daily News

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Yael L. Maxwell

July 15, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Shelley Wood

February 14, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

Advertisement

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Weight-Loss Medications Should Be Part of Cardiology’s Arsenal: ACC

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Tirzepatide Provides Sustained BP Reduction in Overweight Adults

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

BP Reductions Last 5 Years After Bariatric Surgery: GATEWAY

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Intermittent Fasting Trial Comes Out (Partly) Positive, but CV Impact Mixed

Higher Subclinical Atherosclerosis in Black Americans Remains Unexplained

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content